Response to the Comment: "Advocating prudent D-dimer testing: constructive perspectives and comments on "How we manage a high D-dimer".
作者信息
Franchini Massimo, Focosi Daniele, Pezzo Mario Piergiulio, Mannucci Pier Mannuccio
机构信息
Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova.
North-Western Tuscany Blood Bank, Pisa University Hospital.
出版信息
Haematologica. 2024 Oct 1;109(10):3454. doi: 10.3324/haematol.2024.285769.
Abstract
摘要
相似文献
1
Response to the Comment: "Advocating prudent D-dimer testing: constructive perspectives and comments on "How we manage a high D-dimer".对评论的回应：“倡导谨慎的D-二聚体检测：对‘我们如何处理高D-二聚体’的建设性观点与评论”
Haematologica. 2024 Oct 1;109(10):3454. doi: 10.3324/haematol.2024.285769.
2
Advocating prudent D-dimer testing: constructive perspectives and comments on 'How we manage a high D-dimer'.倡导谨慎的D-二聚体检测：对《我们如何处理高D-二聚体》的建设性观点与评论
Haematologica. 2024 Oct 1;109(10):3452-3453. doi: 10.3324/haematol.2024.285691.
3
Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.血浆D-二聚体水平与纤维蛋白原/纤维蛋白降解产物（FDP）之间的关联用于排除血栓栓塞性疾病。
J Thromb Thrombolysis. 2006 Apr;21(2):199-202. doi: 10.1007/s11239-006-4837-9.
4
Evaluation of a new automated quantitative D-dimer, advanced D-dimer, in patients suspected of venous thromboembolism: a comment on correlation of D-dimer assays.对疑似静脉血栓栓塞症患者新型自动化定量D-二聚体（高级D-二聚体）的评估：关于D-二聚体检测相关性的评论
Blood Coagul Fibrinolysis. 2003 Apr;14(3):313-5. doi: 10.1097/00001721-200304000-00017.
5
C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?斯皮德韦尔研究中C反应蛋白、纤维蛋白D-二聚体与缺血性心脏病发病：炎症与纤维蛋白周转在发病机制中有关联吗？
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):603-10. doi: 10.1161/01.atv.21.4.603.
6
Response to the comments on 'point of care D-dimer testing in the emergency department--a bioequivalence study' and erratum to the results.对“急诊科即时D-二聚体检测——一项生物等效性研究”评论的回复及结果勘误
Ann Lab Med. 2014 Jan;34(1):66-7. doi: 10.3343/alm.2014.34.1.66. Epub 2013 Dec 6.
7
[Analysis of D-dimer laboratory findings and clinical evaluation].[D-二聚体实验室检查结果分析与临床评估]
Orv Hetil. 2017 Dec;158(50):1971-1976. doi: 10.1556/650.2017.30909.
8
Diagnostic possibilities of specific fibrin(ogen) degradation products in relation to venous thromboembolism.特定纤维蛋白（原）降解产物与静脉血栓栓塞症相关的诊断可能性
Blood Coagul Fibrinolysis. 2013 Apr;24(3):297-304. doi: 10.1097/MBC.0b013e32835bdcbd.
9
Comments on point of care D-dimer testing in the emergency department: a bioequivalence study.急诊科即时检测D-二聚体的评论：一项生物等效性研究。
Ann Lab Med. 2014 Jan;34(1):64-5. doi: 10.3343/alm.2014.34.1.64. Epub 2013 Dec 6.
10
High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.高纤维蛋白/纤维蛋白原降解产物与纤维蛋白原比值与严重创伤患者的28天死亡率及大量输血相关。
Eur J Trauma Emerg Surg. 2018 Apr;44(2):291-298. doi: 10.1007/s00068-017-0844-0. Epub 2017 Sep 18.
本文引用的文献
1
D-dimer Levels for the exclusion of pulmonary embolism: making sense of international guideline recommendations.用于排除肺栓塞的D-二聚体水平：解读国际指南建议
J Thromb Haemost. 2024 Mar;22(3):604-608. doi: 10.1016/j.jtha.2023.12.015. Epub 2023 Dec 20.
2
How we manage a high D-dimer.如何管理高 D-二聚体。
Haematologica. 2024 Apr 1;109(4):1035-1045. doi: 10.3324/haematol.2023.283966.
3
D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19.D-二聚体——正常水平与因多种情况导致的升高水平，包括“D-二聚体血症”、炎症、血栓栓塞、弥散性血管内凝血和 COVID-19。
Semin Thromb Hemost. 2022 Sep;48(6):672-679. doi: 10.1055/s-0042-1748193. Epub 2022 Jul 8.
4
Diagnostic performance of D-dimer in predicting venous thromboembolism and acute aortic dissection.D - 二聚体在预测静脉血栓栓塞症和急性主动脉夹层中的诊断效能。
Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):559–566. doi: 10.1177/2048872620907322. Epub 2020 Mar 18.
Zotero 插件